Faster Science, Better Drugs

The Stanford PhD who built DSPy thought he was just creating better prompts—until he realized he'd accidentally invented a new paradigm that makes LLMs actually programmable. While everyone obsesses over whether LLMs will get us to AGI, Omar Khattab is solving a more urgent probl ... Show More

a16z cofounders Marc Andreessen and Ben Horowitz join a16z general partner Erik Torenberg and Not Boring founder Packy McCormick for a conversation on how the media and information ecosystem has changed over the past decade. The discussion breaks down the shift toward a more open ... Show More

a16z General Partner Alex Rampell joined the Technology Brothers Podcast Network following the announcement of Andreessen Horowitz’s new fund to discuss what drives founders to build enduring companies. Drawing on his journey from early software entrepreneur to leading a16z’s app ... Show More

On this week’s episode of No Priors, Sarah Guo is joined by leading members of the teams at Vevo Therapeutics and the Arc Institute – Nima Alidoust, CEO/Co-Founder at Vevo Therapeutics; Johnny Yu, CSO/Co-Founder at Vevo Therapeutics; Patrick Hsu, CEO/Co-Founder at Arc Institute; ... Show More

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ... Show More

<p>Cancer care in the U.S. costs over $250 billion each year, and nearly 2 million Americans receive a new diagnosis annually, yet too often the journey begins with silence: no call, no plan, no guide.</p><p>In this episode, a16z’s Vineeta Agarwala and Jay Rughani talk with Thyme ... Show More

Jacob Kimmel thinks he can find the transcription factors to reverse aging. We do a deep dive on why this might be plausible and why evolution hasn’t optimized for longevity. We also talk about why drug discovery has been getting exponentially harder, and what a new platform for ... Show More

Will eating mint cancel out the feeling of spice in your mouth? How do you manipulate aroma compounds to mimic the taste of lemon? When it comes to the science of flavor, there is no shortage of questions to ask. On this episode, Dr. Samantha Yammine is joined by renowned flavor ... Show More

<p><span data-preserver-spaces="true">Today's guest is Liran Belenzon, Co-founder and CEO of BenchSci. BenchSci is a global leader in AI solutions for preclinical R&D that helps decipher complex biomedical research using proprietary technology. Liran joins us to discuss how AI is ... Show More

Science doesn’t always get it right the first time—and that’s part of the journey. In this anniversary episode, we explore how ideas about nerve damage, sustainable materials and alien life have done a full 180. Recommended Reading Celebrating 180 Years of Scientific American 180 ... Show More

Step inside DeepMind's laboratories and you'll find researchers studying DNA to understand the mysteries of life, seeking new ways to use nuclear energy, or putting AI to the test in mind-bending areas of maths. In this episode, Hannah meets Pushmeet Kohli, the head of science at ... Show More

Jon Krohn joins us for a year-end episode about 2020’s biggest data science breakthroughs and for a big podcast announcement for 2021. In this episode you will learn: Global warming [4:37] Our big podcast announcement [6:57] Who is Jon Krohn? [12:14] Top 3 technological brea ... Show More